Elevated IGFBP3 expression correlates with poor prognosis of pancreatic ductal adenocarcinoma, breast cancer, oral squamous cell carcinoma, papillary thyroid carcinoma and colorectal cancer [45, 54, 68–72]. This evidence concerns the gene IGFBP3 and thyroid gland papillary carcinoma.